Head and neck lipoblastoma in children: A case report and systematic review

Justyna Tyra1, Paulina Mierzwińska-Dolny2, Andrew J Fishman3

  • 1Children's Hospital of Bydgoszcz, Department of Otolaryngology, Audiology and Phoniatrics, Pediatric Cochlear Implant Program, Bydgoszcz, Poland.

Insights

Lipoblastoma, a rare pediatric tumor, is best treated with complete surgical excision. Recurrence is possible, necessitating long-term follow-up for this rapidly growing adipose mass.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Head and Neck Surgery

Background:

  • Lipoblastoma is a rare, benign tumor of embryonal fat cells, predominantly affecting infants and young children.
  • This study reviews 83 pediatric cases of head and neck lipoblastoma from 1964-2022.
  • A case of extensive infratemporal fossa and parapharyngeal space lipoblastoma in a 10-month-old is presented.

Observation:

  • The review identified 83 pediatric lipoblastomas, with 27% in the head and 65% in the neck.
  • Tumor locations varied, with a slight predominance in males (48%) versus females (45%).
  • Patient ages ranged from neonates to 15 years.

Findings:

  • Complete surgical excision is the primary treatment for lipoblastoma.
  • Post-surgical recurrence was observed in 6% of cases.
  • This case highlights the challenges of extensive head and neck lipoblastoma, involving V2 and V3 cranial nerves.

Implications:

  • Complete surgical excision is the recommended treatment for lipoblastoma.
  • Interdisciplinary teams and advanced techniques like endoscopy and microdebrider aid in complex cases.
  • Long-term follow-up is crucial due to the potential for tumor recurrence.
Abstract